• Extreme Heat Causes Major Health Problems for Older Adults (PR Newswire)
   
• Pain Medicine Experts Recommend Safe and Responsible Use of Acetaminophen (PR Newswire)
   
• Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? (PR Newswire)
   
• Health Care Reform and Chronic Disease (PR Newswire)
   
• OCI Analytic Uncovers Duplicate Billing in Over 4% Of Workers' Comp Claims (PR Newswire)
   
• Statement by John Bailey, Chief Scientist The Personal Care Products Council, Response to EWG's 2009 Sunscreen Report (PR Newswire)
   
• Florida State Tobacco Tax Increase May Prompt Smokers to Quit Spontaneously (PR Newswire)
   
• New Mexico Supreme Court Ruling Enhances Air Ambulance Safety (PR Newswire)
   
• Leukemia & Lymphoma Society Recognizes Aurora Physician as Man of the Year (PR Newswire)
   
• Ohio Supreme Court Strikes a Blow to Planned Parenthood in Upholding Regulation of 'Abortion Pill' (PR Newswire)
   
• American Society of Medical Doctors Established to Protect the Bond Between Physicians and Patients; Organizing Doctors to Oppose Government-Run Health Care (PR Newswire)
   
• Lixte Biotechnology Holdings' Lead Compound, LB-1.2, Enhances the Effectiveness of Standard Cancer Chemotherapy in Animal Models (PR Newswire)
   
• Acura and King Receive FDA Complete Response Letter Regarding Acurox(R)   (PR Newswire)
   
• FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter (PR Newswire)
   
• Nephros Receives 510k Approval for Dual Stage Ultrafilters (PR Newswire)
   
• Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment (PR Newswire)
   
• CombinatoRx and Neuromed Sign Merger Agreement (PR Newswire)
   
• ACT Announces Partnership With Gilead Sciences Inc. (PR Newswire)
   
• CDC's National Center for Environmental Health Works with Thomson Reuters to Help Identify and Track Illnesses Related to Harmful Algal Blooms (PR Newswire)
   
• Crystal Heart Award Presented to Telemundo for Coverage of Organ Donation (PR Newswire)
   
• WuXi PharmaTech Receives Award from BASF (PR Newswire)
   
• Current Status of the Development Programs of New Indications and Formulations for Aricept(R) for Enhancing Patient Value (PR Newswire)
   
• Successful Beginning for Wellstone Muscular Dystrophy Center at Boston Biomedical Research Institute (PR Newswire)
   

Back to Top Navigational Aid

Links:  Pharm/Biotech Resources,  Pharm/Biotech Jobs

• New Report Finds Obesity Epidemic Increases, Mississippi Weighs in as Heaviest State (PR Newswire)
   
• New EPI Healthcare Study by June O'Neill Shows Uninsured 'Crisis' Wildly Overestimated (PR Newswire)
   
• Pennsylvania Governor Rendell Ceremonially Signs Four Health Care Bills That Will Reduce Costs, Improve Access and Quality (PR Newswire)
   
• New Study Shows Many Unplanned Quit Smoking Attempts are Successful (PR Newswire)
   
• Oral Cancer Foundation Praised for Its Social Media Efforts (PR Newswire)
   
• Crestor Patent Invalidity Evidence Uncovered By Article One Partners Community (PR Newswire)
   
• Infants Should Be Screened for Hip Trouble (PR Newswire)
   
• Joint Replacement Patients with Diabetes Greatly Benefit from Controlled Glucose (PR Newswire)
   
• The 'Other' Cruciate Ligament: Newer Treatments for PCL Tears (PR Newswire)
   
• deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia (PR Newswire)
   
• Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment (PR Newswire)
   
• Hard To Treat Diseases (HTDS) Clinical Trial Update on Therapeutic effects of Combined Treatment With Ribavirin And Tiazofurin (PR Newswire)
   
• Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine (PR Newswire)
   
• WellPoint Recovers and Saves $75 Million Through Anti-Fraud Programs and Investigations in 2008 (PR Newswire)
   
• NeoStem Raises Additional Funds from Principals of Suzhou Erye Pharmaceuticals Company Ltd. and U.S. Institutional and Private Investors, Bringing the Total Recent Financings to Over $15 Million; Funds Will Support Expansion Activities in the United State (PR Newswire)
   
• Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement (PR Newswire)
   
• Morphotek(R), Inc. Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and Infectious Disease (PR Newswire)
   
• Prince William Health System Completes Merger With Novant Health to Expand Quality Health Care in Northern Virginia (PR Newswire)
   
• MDS Inc. Completes Divestiture of MDS Pharma Services Phase II-IV Operations (PR Newswire)
   

Back to Top Navigational Aid

Links:  Pharm/Biotech Resources,  Pharm/Biotech Jobs

• Surgeons Warn: Skateboarding Tough on Feet, Ankles (PR Newswire)
   
• Recent News Reports of Sweetener Reformulations Raise Questions About Motivations (PR Newswire)
   
• Pennsylvania Patient Safety Authority Releases June Advisory (PR Newswire)
   
• Wisconsin Tobacco Tax Increase Is Positive Step for Health, but Budget Disappoints by Cutting Funding for Tobacco Prevention Programs (PR Newswire)
   
• Michigan Passes Legislation to License Physical Therapist Assistants (PR Newswire)
   
• Cardinal Rigali Protests Move to Fund Abortion in District of Columbia (PR Newswire)
   
• Bladder Cancer No Longer a Death Sentence (PR Newswire)
   
• Centocor Ortho Biotech Inc. Awarded $1.67 Billion Patent Jury Verdict from Abbott Laboratories (PR Newswire)
   
• New Data: Efficacy and Responder Analyses of Divigel(R) (estradiol gel) 0.1 percent for the Treatment of Menopause (PR Newswire)
   
• Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM211, a Novel Product Candidate for the Treatment of Respiratory Diseases (PR Newswire)
   
• PROLOR Biotech Awarded Two U.S. Patents for Its Longer-Acting Human Growth Hormone and Longer-Acting Erythropoietin (PR Newswire)
   
• EFSA Issues Positive Safety Statement for the Use of Chromium Picolinate in EU Food Supplements (PR Newswire)
   
• Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder (PR Newswire)
   
• FDA Inspects Hovione's API Manufacturing Plant in Macau (PR Newswire)
   
• Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products (PR Newswire)
   
• Canadian Bio Med Attacks World's Leading Cause of Blindness (PR Newswire)
   
• CVS/pharmacy and MinuteClinic Receive Award of Excellence from National Influenza Vaccine Summit (PR Newswire)
   
• Chiltern Opens Office in Budapest, Hungary (PR Newswire)
   
• Biopure Receives Notice of Nasdaq Delisting (PR Newswire)
   
• Aton Pharma CEO Mike Wells Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Winner; (PR Newswire)
   

Back to Top Navigational Aid

Links:  Pharm/Biotech Resources,  Pharm/Biotech Jobs

• American Society of Anesthesiologists Continues to Ignore Over Medication Risks (PR Newswire)
   
• AACE Response to Insulin Glargine Cancer Risk Articles in Diabetologia (PR Newswire)
   
• Pew Report Documents Challenges Faced by Philadelphia in Paying for City Workers' Pensions and Health Care (PR Newswire)
   
• Air Methods Petitions NTSB for Reconsideration of Probable Cause Determination (PR Newswire)
   
• AMA Manual of Style, the 'Bible' for Medical and Scientific Publishing, Gains Online Presence (PR Newswire)
   
• Miami Physician Sentenced to 97 Months in Prison for Role in $10 Million Medicare Fraud Scheme (PR Newswire)
   
• Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) (PR Newswire)
   
• Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia (PR Newswire)
   
• AlphaRx and Gaia BioPharma Report Positive Efficacy Results in a Pre-Clinical Trial of GAI-122 Injectable Nano-emulsion for Post-operative Delirium (PR Newswire)
   
• AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain (PR Newswire)
   
• Hospira Receives FDA Approval for Azithromycin for Injection (PR Newswire)
   
• Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech (PR Newswire)
   
• Mylan Announces Strategic Collaboration with Biocon to Enter the Global Generic Biologics Market (PR Newswire)
   
• Bayer CropScience and Monsanto Sign Cross Licensing Agreement on Herbicide Tolerance Traits in Rapeseed/Canola (PR Newswire)
   
• MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants (PR Newswire)
   
• Perot Systems Wins Over $119 Million CDC Contract (PR Newswire)
   
• Boston Heart Lab Named 'Most Promising Early Stage Company' 2009 by Silicom Ventures (PR Newswire)
   
• WuXi PharmaTech Named a Top Ten Chinese Outsourcing Enterprise (PR Newswire)
   
• Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications (PR Newswire)
   
• Biostar Pharmaceuticals, Inc. Begins Construction of Raw Material Processing Facility of the Herbal Plantation Base (PR Newswire)
   

Back to Top Navigational Aid

Links:  Pharm/Biotech Resources,  Pharm/Biotech Jobs

• Sudden Cardiac Arrest Foundation Mourns the Loss of Michael Jackson (PR Newswire)
   
• American Heart Association Extends Sympathy to Family of Singer Michael Jackson (PR Newswire)
   
• Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Action (PR Newswire)
   
• Caraco Pharmaceutical Laboratories, Ltd. Updates on Financial Position (PR Newswire)
   
• Groups to Congress: Don't Sacrifice Patient Safety to Lower Health Costs (PR Newswire)
   
• Eight Miami-Area Residents Charged in $22 Million Medicare Fraud Scheme Involving Home Health Care Agencies (PR Newswire)
   
• More Gene Mutations Linked to Autism Risk (PR Newswire)
   
• SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (PR Newswire)
   
• Positive CHMP Opinion for JAVLOR(R) in Metastatic Treatment of Bladder Cancer After Failure of a Prior Platinum-Containing Regimen (PR Newswire)
   
• Dermatologic and Ophthalmic Drugs Advisory Committee Unanimously Recommends Bepreve(TM) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis (PR Newswire)
   
• Immucor Responds To FDA Notice (PR Newswire)
   
• ICON Central Laboratories in Singapore Moves to New Facility to Meet Growing Demand (PR Newswire)
   
• Syngenta and Evogene to Collaborate on Soybean Nematode Resistance (PR Newswire)
   
• CVS Caremark Recognized with Gold Award from National Business Group on Health for Promoting Healthy Lifestyles for Employees (PR Newswire)
   
• Jury Renders Verdict for Ormco - Align's Invisalign(R) Product Infringes Ormco Patent (PR Newswire)
   
• Align Technology Announces Jury Verdict in Patent Litigation With Ormco Corporation (PR Newswire)
   
• Discus Dental Files Suit to Protect BriteSmile(R) Trademark (PR Newswire)
   
• Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus Meeting on the Primary Treatment of Early Breast Cancer (PR Newswire)
   

Back to Top Navigational Aid

Links:  Pharm/Biotech Resources,  Pharm/Biotech Jobs